去势抵抗性前列腺癌-话题@MedSci

#去势抵抗性前列腺癌#

112篇内容 | 3798人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1342151, encodeId=a1261342151fa, content=<a href='/topic/show?id=da143e23485' target=_blank style='color:#2F92EE;'>#去势抵抗性前列腺癌#</a>, objectTitle=Eur Urol：锕-225-PSMA-617在镥-177-PSMA治疗失败后的晚期转移性去势抵抗性前列腺癌中的活性和不良反应 , objectType=article, longId=204687, objectId=679620468e97, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=679620468e97, replyNumber=0, likeNumber=72, createdTime=2020-12-21, rootId=0, userName=ms1948154235210413, userId=464b2500186, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=679620468e97, moduleTitle=Eur Urol：锕-225-PSMA-617在镥-177-PSMA治疗失败后的晚期转移性去势抵抗性前列腺癌中的活性和不良反应 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=679620468e97)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1342150, encodeId=cf1113421503c, content=<a href='/topic/show?id=da143e23485' target=_blank style='color:#2F92EE;'>#去势抵抗性前列腺癌#</a>, objectTitle=Prostate Cancer P D：转移去势抵抗性前列腺癌患者中CTCs和tdEVs的自动计数和表型特征分析 , objectType=article, longId=204403, objectId=1aa720440321, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1aa720440321, replyNumber=0, likeNumber=148, createdTime=2020-12-12, rootId=0, userName=ms1948154235210413, userId=464b2500186, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1aa720440321, moduleTitle=Prostate Cancer P D：转移去势抵抗性前列腺癌患者中CTCs和tdEVs的自动计数和表型特征分析 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1aa720440321)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1342149, encodeId=49aa134214902, content=<a href='/topic/show?id=da143e23485' target=_blank style='color:#2F92EE;'>#去势抵抗性前列腺癌#</a>, objectTitle=NMPA批准XTANDI（恩杂鲁胺软胶囊）治疗非转移性去势抵抗性前列腺癌, objectType=article, longId=203137, objectId=f21a20313e8c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f21a20313e8c, replyNumber=0, likeNumber=87, createdTime=2020-11-10, rootId=0, userName=ms1948154235210413, userId=464b2500186, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f21a20313e8c, moduleTitle=NMPA批准XTANDI（恩杂鲁胺软胶囊）治疗非转移性去势抵抗性前列腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f21a20313e8c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1342148, encodeId=697b134214808, content=<a href='/topic/show?id=da143e23485' target=_blank style='color:#2F92EE;'>#去势抵抗性前列腺癌#</a>, objectTitle=Oncogene：去势抵抗性前列腺癌中神经内分泌分化的micromRNA决定因素研究 , objectType=article, longId=202454, objectId=ec52202454f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec52202454f3, replyNumber=0, likeNumber=101, createdTime=2020-10-26, rootId=0, userName=ms1948154235210413, userId=464b2500186, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec52202454f3, moduleTitle=Oncogene：去势抵抗性前列腺癌中神经内分泌分化的micromRNA决定因素研究 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec52202454f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1342147, encodeId=491f134214e89, content=<a href='/topic/show?id=da143e23485' target=_blank style='color:#2F92EE;'>#去势抵抗性前列腺癌#</a>, objectTitle=Prostate：去势抵抗性前列腺癌中雄激素受体信号靶向治疗和紫杉醇化疗能够诱导内脏转移, objectType=article, longId=202452, objectId=4259202452b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4259202452b7, replyNumber=0, likeNumber=85, createdTime=2020-10-26, rootId=0, userName=ms1948154235210413, userId=464b2500186, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4259202452b7, moduleTitle=Prostate：去势抵抗性前列腺癌中雄激素受体信号靶向治疗和紫杉醇化疗能够诱导内脏转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4259202452b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1342146, encodeId=f8d21342146a2, content=<a href='/topic/show?id=da143e23485' target=_blank style='color:#2F92EE;'>#去势抵抗性前列腺癌#</a>, objectTitle=Eur Urol：恩杂鲁胺治疗的非转移去势抵抗性前列腺癌男性的前列腺特异性抗原进展研究, objectType=article, longId=202311, objectId=bf812023119e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf812023119e, replyNumber=0, likeNumber=71, createdTime=2020-10-22, rootId=0, userName=ms1948154235210413, userId=464b2500186, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf812023119e, moduleTitle=Eur Urol：恩杂鲁胺治疗的非转移去势抵抗性前列腺癌男性的前列腺特异性抗原进展研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf812023119e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1342145, encodeId=d1271342145ee, content=<a href='/topic/show?id=da143e23485' target=_blank style='color:#2F92EE;'>#去势抵抗性前列腺癌#</a>, objectTitle=Br J Cancer：雄激素受体信号减弱多西他赛对去势抵抗性前列腺癌的治疗效果, objectType=article, longId=201994, objectId=470f2019944e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=470f2019944e, replyNumber=0, likeNumber=72, createdTime=2020-10-13, rootId=0, userName=ms1948154235210413, userId=464b2500186, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=470f2019944e, moduleTitle=Br J Cancer：雄激素受体信号减弱多西他赛对去势抵抗性前列腺癌的治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=470f2019944e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1342144, encodeId=9fa41342144c5, content=<a href='/topic/show?id=da143e23485' target=_blank style='color:#2F92EE;'>#去势抵抗性前列腺癌#</a>, objectTitle=Clin Cancer Res：转移性去势抵抗性前列腺癌c-MET和雄激素受体双重阻断:恩扎鲁胺和克唑替尼联合应用的一期研究, objectType=article, longId=201364, objectId=cf922013647f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf922013647f, replyNumber=0, likeNumber=64, createdTime=2020-09-30, rootId=0, userName=ms1948154235210413, userId=464b2500186, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf922013647f, moduleTitle=Clin Cancer Res：转移性去势抵抗性前列腺癌c-MET和雄激素受体双重阻断:恩扎鲁胺和克唑替尼联合应用的一期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf922013647f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1342143, encodeId=e4191342143fa, content=<a href='/topic/show?id=da143e23485' target=_blank style='color:#2F92EE;'>#去势抵抗性前列腺癌#</a>, objectTitle=J Urol：去势敏感性和去势抵抗性前列腺癌的基因组变异比较分析 , objectType=article, longId=200972, objectId=d6342009e22a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6342009e22a, replyNumber=0, likeNumber=74, createdTime=2020-09-22, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6342009e22a, moduleTitle=J Urol：去势敏感性和去势抵抗性前列腺癌的基因组变异比较分析 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6342009e22a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1342142, encodeId=68e81342142a0, content=<a href='/topic/show?id=da143e23485' target=_blank style='color:#2F92EE;'>#去势抵抗性前列腺癌#</a>, objectTitle=Lancet oncol：卡巴他赛治疗的转移性去势抵抗性前列腺癌患者的生活质量, objectType=article, longId=200700, objectId=cfcb200e0043, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cfcb200e0043, replyNumber=0, likeNumber=124, createdTime=2020-09-17, rootId=0, userName=ms1948154235210413, userId=464b2500186, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cfcb200e0043, moduleTitle=Lancet oncol：卡巴他赛治疗的转移性去势抵抗性前列腺癌患者的生活质量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cfcb200e0043)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1342141, encodeId=3b4b134214193, content=<a href='/topic/show?id=da143e23485' target=_blank style='color:#2F92EE;'>#去势抵抗性前列腺癌#</a>, objectTitle=Clin Cancer Res：阿帕他胺用于非转移性去势抵抗性前列腺癌的暴露-反应分析, objectType=article, longId=200657, objectId=46a120065e1f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46a120065e1f, replyNumber=0, likeNumber=78, createdTime=2020-09-15, rootId=0, userName=ms1948154235210413, userId=464b2500186, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46a120065e1f, moduleTitle=Clin Cancer Res：阿帕他胺用于非转移性去势抵抗性前列腺癌的暴露-反应分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=46a120065e1f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1342140, encodeId=a1f11342140ee, content=<a href='/topic/show?id=da143e23485' target=_blank style='color:#2F92EE;'>#去势抵抗性前列腺癌#</a>, objectTitle=Prostate Cancer P D：镭-223治疗去势抵抗性前列腺癌研究 , objectType=article, longId=200059, objectId=62c6200059f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62c6200059f7, replyNumber=0, likeNumber=93, createdTime=2020-09-01, rootId=0, userName=ms1948154235210413, userId=464b2500186, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62c6200059f7, moduleTitle=Prostate Cancer P D：镭-223治疗去势抵抗性前列腺癌研究 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62c6200059f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1342139, encodeId=8cb913421395d, content=<a href='/topic/show?id=da143e23485' target=_blank style='color:#2F92EE;'>#去势抵抗性前列腺癌#</a>, objectTitle=Cell Death & Disease：LINC00675能够促进去势抵抗性前列腺癌的进展, objectType=article, longId=200057, objectId=0de920005e55, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0de920005e55, replyNumber=0, likeNumber=70, createdTime=2020-09-01, rootId=0, userName=ms1948154235210413, userId=464b2500186, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0de920005e55, moduleTitle=Cell Death & Disease：LINC00675能够促进去势抵抗性前列腺癌的进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0de920005e55)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1342138, encodeId=829913421382c, content=<a href='/topic/show?id=da143e23485' target=_blank style='color:#2F92EE;'>#去势抵抗性前列腺癌#</a>, objectTitle=Clin Cancer Res：阿帕鲁胺联合醋酸阿比特龙和泼尼松治疗转移性去势抵抗性前列腺癌！, objectType=article, longId=198652, objectId=f4a019865234, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4a019865234, replyNumber=0, likeNumber=112, createdTime=2020-08-05, rootId=0, userName=ms1948154235210413, userId=464b2500186, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4a019865234, moduleTitle=Clin Cancer Res：阿帕鲁胺联合醋酸阿比特龙和泼尼松治疗转移性去势抵抗性前列腺癌！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4a019865234)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1342137, encodeId=27fc134213eda, content=<a href='/topic/show?id=da143e23485' target=_blank style='color:#2F92EE;'>#去势抵抗性前列腺癌#</a>, objectTitle=Brit J Cancer：血浆肿瘤DNA是转移去势抵抗性前列腺癌治疗响应的早期指标 , objectType=article, longId=198232, objectId=860f19823206, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=860f19823206, replyNumber=0, likeNumber=94, createdTime=2020-07-30, rootId=0, userName=ms1948154235210413, userId=464b2500186, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=860f19823206, moduleTitle=Brit J Cancer：血浆肿瘤DNA是转移去势抵抗性前列腺癌治疗响应的早期指标 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=860f19823206)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1342136, encodeId=88b0134213654, content=<a href='/topic/show?id=da143e23485' target=_blank style='color:#2F92EE;'>#去势抵抗性前列腺癌#</a>, objectTitle=Eur Urol：转移去势抵抗性前列腺癌男性双相雄激素治疗的多队列开放标签II期试验, objectType=article, longId=197385, objectId=1ef219e38501, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ef219e38501, replyNumber=0, likeNumber=122, createdTime=2020-07-13, rootId=0, userName=ms1948154235210413, userId=464b2500186, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ef219e38501, moduleTitle=Eur Urol：转移去势抵抗性前列腺癌男性双相雄激素治疗的多队列开放标签II期试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ef219e38501)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1342135, encodeId=aba413421350e, content=<a href='/topic/show?id=da143e23485' target=_blank style='color:#2F92EE;'>#去势抵抗性前列腺癌#</a>, objectTitle=Clin Cancer Res：非转移去势抵抗性前列腺癌中阿帕鲁胺治疗效果和安全性的暴露-响应关系研究, objectType=article, longId=196826, objectId=c918196826c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c918196826c7, replyNumber=0, likeNumber=87, createdTime=2020-07-02, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c918196826c7, moduleTitle=Clin Cancer Res：非转移去势抵抗性前列腺癌中阿帕鲁胺治疗效果和安全性的暴露-响应关系研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c918196826c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1342134, encodeId=92821342134bb, content=<a href='/topic/show?id=da143e23485' target=_blank style='color:#2F92EE;'>#去势抵抗性前列腺癌#</a>, objectTitle=Eur Urol：无化疗转移去势抵抗性前列腺癌男性恩杂鲁胺治疗5年生存预测和安全结果研究 , objectType=article, longId=196183, objectId=b62a19618381, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b62a19618381, replyNumber=0, likeNumber=86, createdTime=2020-06-22, rootId=0, userName=ms1948154235210413, userId=464b2500186, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b62a19618381, moduleTitle=Eur Urol：无化疗转移去势抵抗性前列腺癌男性恩杂鲁胺治疗5年生存预测和安全结果研究 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b62a19618381)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1342133, encodeId=d65e134213392, content=<a href='/topic/show?id=da143e23485' target=_blank style='color:#2F92EE;'>#去势抵抗性前列腺癌#</a>, objectTitle=Nat Commun：MAO抑制剂phenelzine和clorgyline能够逆转去势抵抗性前列腺癌中enzalutamide的抗性, objectType=article, longId=195968, objectId=7286195968f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7286195968f2, replyNumber=0, likeNumber=92, createdTime=2020-06-18, rootId=0, userName=ms1948154235210413, userId=464b2500186, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7286195968f2, moduleTitle=Nat Commun：MAO抑制剂phenelzine和clorgyline能够逆转去势抵抗性前列腺癌中enzalutamide的抗性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7286195968f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1342132, encodeId=a22713421321c, content=<a href='/topic/show?id=da143e23485' target=_blank style='color:#2F92EE;'>#去势抵抗性前列腺癌#</a>, objectTitle=Prostate Cancer P D：镭-223和恩杂鲁胺或阿比特龙/强的松同时或分层治疗转移去势抵抗性前列腺癌, objectType=article, longId=195245, objectId=a2df19524559, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2df19524559, replyNumber=0, likeNumber=96, createdTime=2020-06-05, rootId=0, userName=ms1948154235210413, userId=464b2500186, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2df19524559, moduleTitle=Prostate Cancer P D：镭-223和恩杂鲁胺或阿比特龙/强的松同时或分层治疗转移去势抵抗性前列腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2df19524559)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

去势抵抗性前列腺癌

2020-05-29

ms1948154235210413 (审核中...)

前往app查看评论内容

#去势抵抗性前列腺癌#

Eur Urol：锕-225-PSMA-617在镥-177-PSMA治疗失败后的晚期转移性去势抵抗性前列腺癌中的活性和不良反应

2020-12-21

ms1948154235210413 (审核中...)

前往app查看评论内容

#去势抵抗性前列腺癌#

Prostate Cancer P D：转移去势抵抗性前列腺癌患者中CTCs和tdEVs的自动计数和表型特征分析

2020-12-12

ms1948154235210413 (审核中...)

前往app查看评论内容

#去势抵抗性前列腺癌#

NMPA批准XTANDI（恩杂鲁胺软胶囊）治疗非转移性去势抵抗性前列腺癌

2020-11-10

ms1948154235210413 (审核中...)

前往app查看评论内容

#去势抵抗性前列腺癌#

Oncogene：去势抵抗性前列腺癌中神经内分泌分化的micromRNA决定因素研究

2020-10-26

ms1948154235210413 (审核中...)

前往app查看评论内容

#去势抵抗性前列腺癌#

Prostate：去势抵抗性前列腺癌中雄激素受体信号靶向治疗和紫杉醇化疗能够诱导内脏转移

2020-10-26

ms1948154235210413 (审核中...)

前往app查看评论内容

#去势抵抗性前列腺癌#

Eur Urol：恩杂鲁胺治疗的非转移去势抵抗性前列腺癌男性的前列腺特异性抗原进展研究

2020-10-22

ms1948154235210413 (审核中...)

前往app查看评论内容

#去势抵抗性前列腺癌#

Br J Cancer：雄激素受体信号减弱多西他赛对去势抵抗性前列腺癌的治疗效果

2020-10-13

ms1948154235210413 (审核中...)

前往app查看评论内容

#去势抵抗性前列腺癌#

Clin Cancer Res：转移性去势抵抗性前列腺癌c-MET和雄激素受体双重阻断:恩扎鲁胺和克唑替尼联合应用的一期研究

2020-09-30

zhouqu_8 (审核中...)

前往app查看评论内容

#去势抵抗性前列腺癌#

J Urol：去势敏感性和去势抵抗性前列腺癌的基因组变异比较分析

2020-09-22

ms1948154235210413 (审核中...)

前往app查看评论内容

#去势抵抗性前列腺癌#

Lancet oncol：卡巴他赛治疗的转移性去势抵抗性前列腺癌患者的生活质量

2020-09-17

ms1948154235210413 (审核中...)

前往app查看评论内容

#去势抵抗性前列腺癌#

Clin Cancer Res：阿帕他胺用于非转移性去势抵抗性前列腺癌的暴露-反应分析

2020-09-15

ms1948154235210413 (审核中...)

前往app查看评论内容

#去势抵抗性前列腺癌#

Prostate Cancer P D：镭-223治疗去势抵抗性前列腺癌研究

2020-09-01

ms1948154235210413 (审核中...)

前往app查看评论内容

#去势抵抗性前列腺癌#

Cell Death & Disease：LINC00675能够促进去势抵抗性前列腺癌的进展

2020-09-01

ms1948154235210413 (审核中...)

前往app查看评论内容

#去势抵抗性前列腺癌#

Clin Cancer Res：阿帕鲁胺联合醋酸阿比特龙和泼尼松治疗转移性去势抵抗性前列腺癌！

2020-08-05

ms1948154235210413 (审核中...)

前往app查看评论内容

#去势抵抗性前列腺癌#

Brit J Cancer：血浆肿瘤DNA是转移去势抵抗性前列腺癌治疗响应的早期指标

2020-07-30

ms1948154235210413 (审核中...)

前往app查看评论内容

#去势抵抗性前列腺癌#

Eur Urol：转移去势抵抗性前列腺癌男性双相雄激素治疗的多队列开放标签II期试验

2020-07-13

zhaojie88 (审核中...)

前往app查看评论内容

#去势抵抗性前列腺癌#

Clin Cancer Res：非转移去势抵抗性前列腺癌中阿帕鲁胺治疗效果和安全性的暴露-响应关系研究

2020-07-02

ms1948154235210413 (审核中...)

前往app查看评论内容

#去势抵抗性前列腺癌#

Eur Urol：无化疗转移去势抵抗性前列腺癌男性恩杂鲁胺治疗5年生存预测和安全结果研究

2020-06-22

ms1948154235210413 (审核中...)

前往app查看评论内容

#去势抵抗性前列腺癌#

Nat Commun：MAO抑制剂phenelzine和clorgyline能够逆转去势抵抗性前列腺癌中enzalutamide的抗性

2020-06-18

ms1948154235210413 (审核中...)

前往app查看评论内容

#去势抵抗性前列腺癌#

Prostate Cancer P D：镭-223和恩杂鲁胺或阿比特龙/强的松同时或分层治疗转移去势抵抗性前列腺癌

2020-06-05

科室
- - 订阅+
  - 更多科室
工具
服务